Pulmonary Nodule, Multiple

2

Review clinical trials related to Pulmonary Nodule, Multiple. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

DOLCE: Determining the Impact of Optellum's Lung Cancer Prediction Solution

This study is a multi-centre prospective observational cohort study recruiting patients with 5-30mm solid and part-solid pulmonary nodules that have been detected on CT chest scans performed as part of routine practice. The aim is to determine whether physician decision making with the AI-based LCP tool, generates clinical and health-economic benefits over the current standard of care of these patients.

Participants needed: 2,000
Trial details
Age: 35+Biological sex: AllType: ObservationalSponsor: Nottingham University Hospitals NHS TrustUpdated: Apr 8, 2025Locations: 10
Eligibility criteria

Are aged 35 years or above [+4]

Have received a diagnosis for cancer in the last 5 years [+5]

Status: Not yet recruiting

Comparative Study on the Efficacy and Safety of Microwave Ablation and Lobectomy in the Treatment of Ground Glass Nodules Located in the Pulmonary Hilar Region

GGO is a characteristic focus of early lung cancer. Due to the abundant peripheral blood vessels and bronchial tissues around the GGO lesions located in pulmonary hilar, only lobectomy could be used for the surgical treat of hilar GGO lesions which will make the significantly decline of the pulmonary function after surgery and affect the quality of life to a great extent. Our previous study has reported a new blunt-tip MWA electrode (MTC-3CA-II3, Vison Medical Inc.) for the treatment of GGO lesions. The blunt-tip MWA electrode could improve the safety of GGO ablation, significantly reduce the occurrence of bleeding and hemoptysis, which made it possible to ablate GGO in the hilar region safely. In this study, the blunt-tip MWA electrode was used in the treatment of patients with hilar GGO lesions, and the efficacy and safety of microwave ablation and lobectomy in the treatment of ground glass nodules located in the pulmonary hilar region were evaluated and compared.

Participants needed: 100
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: RenJi HospitalUpdated: Aug 11, 2022
Eligibility criteria

The age ranged from 18 to 75 years old, male or female; [+6]

The general condition of the patient is very poor, ECOG physical fitness score >... [+4]